JieJun Wang
Impact in
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Gastric Cancer Management and Outcomes 18
- Neurology 12
- Intracranial Aneurysms: Treatment and Complications 11
- Co-authors
- Guanzhen Yu (17 shared papers)Jun Pan (7 shared papers)Keping Xie (4 shared papers)Wenxing Qin (2 shared papers)Te Liu (2 shared papers)Yongyi Huang (2 shared papers)Ying Chen (4 shared papers)Xi Wang (3 shared papers)
- Journals
- Frontiers in Neurology (8 papers)BMC Cancer (4 papers)Medical Oncology (4 papers)Oncotarget (3 papers)Buildings (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
JieJun Wang
114 papers receiving 7.2k citations
JieJun Wang's Hit Papers
Peers
Comparison fields: 5 of 115
- Hepatology 4k
- Cancer Research 521
- Oncology 752
- Pulmonary and Respiratory Medicine 489
- Molecular Biology 899
Countries citing papers authored by JieJun Wang
This map shows the geographic impact of JieJun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JieJun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JieJun Wang more than expected).
Fields of papers citing papers by JieJun Wang
This network shows the impact of papers produced by JieJun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JieJun Wang. The network helps show where JieJun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside JieJun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2008 | 5101 |
| 2 | 2018 | 327 | |
| 3 | 2009 | 139 | |
| 4 | 2013 | 118 | |
| 5 | 2010 | 77 | |
| 6 | 2022 | 70 | |
| 7 | 2012 | 66 | |
| 8 | 2015 | 66 | |
| 9 | 2008 | 59 | |
| 10 | 2012 | 57 | |
| 11 | 2017 | 57 | |
| 12 | 2015 | 56 | |
| 13 | 2018 | 55 | |
| 14 | 2014 | 48 | |
| 15 | 2014 | 45 | |
| 16 | 2010 | 44 | |
| 17 | 2013 | 42 | |
| 18 | 2007 | 40 | |
| 19 | 2014 | 39 | |
| 20 | 2015 | 35 |
About JieJun Wang
JieJun Wang is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Building and Construction, Cancer Research and Anesthesiology and Pain Medicine, having authored 123 papers that have together received 7.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (18 papers), Intracranial Aneurysms: Treatment and Complications (11 papers), Wood Treatment and Properties (8 papers), Advanced Memory and Neural Computing (8 papers), Structural Load-Bearing Analysis (8 papers), Optical Polarization and Ellipsometry (6 papers), Heat Transfer and Optimization (5 papers) and Pain Management and Opioid Use (5 papers). The work is most often cited by research in Hepatology (4k citations), Cancer Research (521 citations), Oncology (752 citations), Pulmonary and Respiratory Medicine (489 citations) and Molecular Biology (899 citations). JieJun Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Guanzhen Yu, Jun Pan, Keping Xie, Wenxing Qin, Te Liu, Yongyi Huang, Ying Chen, Ying Chen, Xi Wang and Ke Liu. Their work appears in journals such as Frontiers in Neurology, BMC Cancer, Medical Oncology, Oncotarget and Buildings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.